首页> 外文会议>European Congress of Oto-Rhino-Laryngology, Head and Neck Surgery >Expression of MTS1 Gene and Its Protein Product in Laryngeal Cancer
【24h】

Expression of MTS1 Gene and Its Protein Product in Laryngeal Cancer

机译:MTS1基因及其蛋白质产品在喉癌中的表达

获取原文

摘要

The MTS1/p16INK4a gene has been identified as a cyclin-dependent kinase inhibitor and may negatively regulate the cell cycle acting as a tumour suppressor. Our purpose was to investigate 9p21 LOH and expression of pl6 protein and their possible prognostic value in laryngeal cancer. 41 patients with laryngeal cancer was analysed. PCR-based techniques were used for investigating 9p21 LOH. Paraffin-embedded tissue sections were immunohistochemically stained with a monoclonal antibody raised against pl6 protein. 9p21 LOH was detected in 10/41 (24,4%) informative tumours. Expression of pl6 protein was observed in 11/41 cases (26,8%) and was significantly correlated with T status (p=0,045), N status (p=0,035) and nodal recurrences (p=0,015). By univariate analysis 9p21 LOH proved to be significantly related to overall survival whereas expression of pl6 protein was related with quicker relapse. Analysis of 9p21 LOH enables the assessment of biology of laryngeal cancer, it can be a prognostic factor of overall survival and pl6 protein has a prognostic value in assessment of disease free survival.
机译:MTS1 / p16kin4a基因已被鉴定为细胞周期蛋白依赖性激酶抑制剂,并且可以负调节作为肿瘤抑制剂的细胞循环。我们的目的是探讨9P21 LOH和PL6蛋白的表达及其在喉癌中可能的预后价值。分析了41例喉癌患者。基于PCR的技术用于研究9P21 LOH。将石蜡嵌入的组织切片用针对PL6蛋白施加的单克隆抗体免疫组织化学染色。在10/41(24,4%)信息肿瘤中检测到9P21 LOH。在11/41例(26,8%)中观察到PL6蛋白的表达,与T状态显着相关(p = 0.045),n状态(p = 0.035)和节点复发(p = 0,015)。通过单变量分析,9P21 LOH被证明与整体存活有关,而PL6蛋白的表达与更快的复发相关。 9P21 LOH的分析能够评估喉癌生物学,它可以是总体存活的预后因素,PL6蛋白具有评估无病生存率的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号